Amedisys Total Non-Operating Income/Expense 2010-2024 | AMED

Amedisys total non-operating income/expense from 2010 to 2024. Total non-operating income/expense can be defined as the sum of all non-operating expenses for the given industry.
Amedisys Annual Total Non-Operating Income/Expense
(Millions of US $)
2023 $-117
2022 $-21
2021 $28
2020 $-8
2019 $-7
2018 $4
2017 $2
2016 $4
2015 $9
2014 $-3
2013 $1
2012 $-6
2011 $-8
2010 $-8
2009 $-9
Amedisys Quarterly Total Non-Operating Income/Expense
(Millions of US $)
2024-09-30 $-1
2024-06-30 $-3
2024-03-31 $-4
2023-12-31 $-5
2023-09-30 $-4
2023-06-30 $-100
2023-03-31 $-8
2022-12-31 $-5
2022-09-30 $-4
2022-06-30 $-7
2022-03-31 $-4
2021-12-31 $-1
2021-09-30 $-1
2021-06-30 $31
2021-03-31 $-1
2020-12-31 $-0
2020-09-30 $-1
2020-06-30 $-5
2020-03-31 $-2
2019-12-31 $-2
2019-09-30 $-3
2019-06-30 $-0
2019-03-31 $-2
2018-12-31 $0
2018-09-30 $1
2018-06-30 $1
2018-03-31 $1
2017-12-31 $-1
2017-09-30 $1
2017-06-30 $2
2017-03-31 $-0
2016-12-31 $1
2016-09-30 $4
2016-06-30 $-0
2016-03-31 $-0
2015-12-31 $6
2015-09-30 $-2
2015-06-30 $3
2015-03-31 $2
2014-12-31 $-0
2014-09-30 $-2
2014-06-30 $-0
2014-03-31 $-0
2013-12-31 $-3
2013-09-30 $6
2013-06-30 $-1
2013-03-31 $-1
2012-12-31 $-2
2012-09-30 $-2
2012-06-30 $-2
2012-03-31 $-1
2011-12-31 $-2
2011-09-30 $-2
2011-06-30 $-2
2011-03-31 $-2
2010-12-31 $-2
2010-09-30 $-1
2010-06-30 $-3
2010-03-31 $-2
2009-12-31 $-3
2009-09-30 $-2
2009-06-30 $-2
2009-03-31 $-3
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $3.166B $2.236B
Amedisys Inc. provides home health and hospice services throughout the U.S. to the growing chronic, co-morbid, and aging American population. The company also offers clinically focused programs for chronic conditions and various diseases such as diabetes, coronary artery disease, congestive heart failure, orthopedics, complex wound care, geriatric surgical recovery, balance retraining, behavioral health and stroke recovery, as well as various rehabilitative programs. It provides hospice services to patients using an interdisciplinary care team comprising a physician, nurses, home health aides, social workers, therapists, dieticians, volunteers, counselors, chaplains and bereavement coordinators, when required. The company depends on reimbursement from Medicare (for chronic care) for a significant portion of its revenues on account of the age demographics of its patient base (average age of 81).
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $20.419B 12.35
Quest Diagnostics (DGX) United States $17.788B 18.03
DaVita (DVA) United States $12.272B 15.87
Encompass Health (EHC) United States $10.397B 24.51
Chemed (CHE) United States $8.402B 25.82
Elanco Animal Health (ELAN) United States $6.955B 16.55
RadNet (RDNT) United States $5.364B 127.25
Option Care Health (OPCH) United States $3.826B 18.13
LifeStance Health (LFST) United States $2.816B 0.00
Addus HomeCare (ADUS) United States $2.313B 27.14
Astrana Health (ASTH) United States $2.305B 36.12
U.S Physical Therapy (USPH) United States $1.434B 37.73
Pennant (PNTG) United States $1.148B 46.42
Aveanna Healthcare Holdings (AVAH) United States $1.127B 0.00
Atai Life Sciences (ATAI) Germany $0.237B 0.00
Daxor (DXR) United States $0.046B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.014B 0.00
Psychemedics (PMD) United States $0.014B 0.00
ATI Physical Therapy (ATIP) United States $0.011B 0.00
Ontrak (OTRK) United States $0.008B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00